CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV
about
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumorsOncolytic virotherapy for pediatric malignancies: future prospectsTargeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcomaAldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children.Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaCalpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma.Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines.FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells.Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma.Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002.RETRACTED: Pediatric sarcomas.
P2860
Q27329466-8A2F1187-5D64-442B-A294-967379D14120Q28069358-F45B2EA6-88DE-49E2-A8F3-F7DE6A2F63CBQ33586736-B3035871-9CD6-48CC-B711-ED3B7E87DA75Q35615455-92A3B346-1BF1-4D41-8DB5-96FA19B311F8Q36109700-09DC8435-AD03-4C62-9291-4B55417CA82BQ36109704-E56E3DFB-1610-4CA8-8922-37C17CD530FAQ37346179-25A823B8-6641-4A58-A1B9-F81DD2DCDDB5Q38615069-59D90B5D-1246-4358-8216-2B392B9FDE17Q38874577-668044E9-D3C4-4F39-AF44-E298A1815587Q39248446-B2F1F241-7E04-4612-8C87-24952D92D886Q42323550-D217E05A-1FEA-46CB-AE46-FA9E1CAF045FQ42373511-B73FC989-7130-417B-BA5C-80FD8AA15F79Q55206301-4F3D9B97-4A6A-461F-A041-9ED81C35B4E3
P2860
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@ast
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@en
type
label
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@ast
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@en
prefLabel
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@ast
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@en
P2093
P2860
P356
P1476
CD133 marks a myogenically pri ...... nt but sensitive to mutant HSV
@en
P2093
Christine S Pressey
G Yancey Gillespie
Gregory K Friedman
Jacqueline N Parker
Joseph G Pressey
Marilyn C Haas
Virginia M Kelly
P2860
P356
10.1002/PBC.24117
P577
2012-03-09T00:00:00Z